Starling Oncology, Inc. (STLN)

NASDAQ: STLN · Real-Time Price · USD

6.13

-0.34 (-5.26%)

At close: Aug 24, 2026, 4:00 PM EDT

6.14

+0.01 (0.16%)

After-hours: Aug 24, 2026, 7:30 PM EDT

Starling Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	587.24	502.73	393.41	324.24	252.48	203
Revenue Growth	38.38%	27.79%	21.33%	28.42%	24.37%	8.26%
Cost of Revenue	495.08	426.29	339.42	264.67	200.39	162.16
Gross Profit	92.17	76.44	54	59.57	52.09	40.85
Selling, General & Admin	111.45	105.57	107.83	113.85	119.69	82.89
Operating Expenses	118.26	112.52	114.12	119.72	124.1	86.23
Operating Income	-26.09	-36.08	-60.12	-60.15	-72.01	-45.38
Interest Expense	-7.63	-11.28	-7.5	-6.78	-4.08	-0.32
Other Non Operating Income (Expenses)	-2.59	-13.38	2.82	-0.35	25.9	3.71
EBT Excluding Unusual Items	-36.31	-60.74	-64.8	-67.28	-50.19	-41.99
Merger & Restructuring Charges	-	-	-	-	-	-0.48
Impairment of Goodwill	-	-	-	-16.87	-9.94	-
Gain (Loss) on Sale of Investments	0.01	0.01	0.13	0.24	0.64	-
Other Unusual Items	-	-	-	0.8	59.4	30.87
Pretax Income	-36.29	-60.74	-64.66	-83.1	-0.09	-11.6
Income Tax Expense	-	-0.13	-	-0.04	-0.24	-0.67
Net Income	-36.29	-60.61	-64.66	-83.07	0.15	-10.93
Preferred Dividends & Other Adjustments	-5.73	-10.3	-11.66	-15.19	0.08	-0.3
Net Income to Common	-30.56	-50.31	-53.01	-67.88	0.07	-10.63
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	101	92	75	74	73	66
Shares Outstanding (Diluted)	101	92	75	74	81	66
Shares Change	25.63%	23.11%	1.76%	-8.51%	21.70%	12.03%
EPS (Basic)	-0.30	-0.54	-0.71	-0.92	0.00	-0.16
EPS (Diluted)	-0.30	-0.54	-0.71	-0.92	-0.21	-0.16
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-3.29	-27.79	-30.33	-40.88	-67.29	-35.53
Free Cash Flow Per Share	-0.03	-0.30	-0.40	-0.55	-0.83	-0.54
Gross Margin	15.69%	15.20%	13.73%	18.37%	20.63%	20.12%
Operating Margin	-4.44%	-7.18%	-15.28%	-18.55%	-28.52%	-22.36%
Profit Margin	-5.20%	-10.01%	-13.47%	-20.93%	0.03%	-5.24%
Free Cash Flow Margin	-0.56%	-5.53%	-7.71%	-12.61%	-26.65%	-17.50%
EBITDA	-19.28	-29.14	-53.83	-54.28	-67.6	-42.04
EBITDA Margin	-3.28%	-5.80%	-13.68%	-16.74%	-26.77%	-20.71%
D&A For EBITDA	6.81	6.94	6.29	5.87	4.41	3.34
EBIT	-26.09	-36.08	-60.12	-60.15	-72.01	-45.38
EBIT Margin	-4.44%	-7.18%	-15.28%	-18.55%	-28.52%	-22.36%
Revenue as Reported	587.24	502.73	393.41	324.24	252.48	203

SEC Filings: 10-K · 10-Q